Cancer Radiation Therapy Market Outlook (2021-2031)

The Cancer Radiation Therapy Market size is expected to reach US$ 136.16 Billion by 2031 from US$ 57.88 Billion in 2024. The market is estimated to record a CAGR of 13.00% from 2025 to 2031.

Executive Summary and Global Market Analysis:

The cancer radiation therapy market is expected to grow rapidly, owing to the rising cancer cases and advancement in the radiation technology. Radiation therapy has a major role in treating various cancers and offers a non-invasive and targeted options for various cancer types, including breast, lung, prostate, and head & neck cancers. Newer technological innovations such as external beam radiation stereotactic radiosurgery, and proton therapy have made treatments more exact, effective, and better for patients. Hospitals are still the main users backed by better healthcare setups in up-and-coming markets. But, the high cost of equipment and limited access in poor areas can limit the market growth.

In line with the adoption rate, the global cancer radiation therapy market stood at US$ 57,884.05 million in 2024 and is expected to reach US$ 136,163.16 million by 2031. Increasing awareness, rising government funding and rising adoption of personalized treatments are also expected to drive this markets growth in near future. Trends like Al integration, hypofractionation, and MR-guided therapy are shaping the future of radiation oncology, making this market poised for sustained expansion over the next decade.

Cancer Radiation Therapy Market Segmentation Analysis:

Key segments that contributed to the derivation of the cancer radiation therapy market analysis are type, cancer type, and end user.

• By type, the cancer radiation therapy market is segmented into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment dominated the market in 2024. 
• By cancer type, the cancer radiation therapy market is segmented into breast cancer, lung cancer, prostate cancer, cervical cancer, head & neck cancer, colorectal cancer and others. The breast cancer segment dominated the market in 2024.
• By end user, the market is segmented into hospitals, ambulatory & radiotherapy centers, specialty clinics, and academic & research institutes. The hospitals segment held the largest share of the market in 2024.

Cancer Radiation Therapy Market Drivers and Opportunities:

Rising Cancer Incidence 

The growing prevalence of cancer is a major driver for the market expansion. Aging populations, lifestyle, environmental pollution, and enhanced diagnostic ability are some of the contributing factors that have led to an increasing incidence of cancer cases in the world. As the number of cases of major cancer such lung, prostate, and breast cancer increases, the demand for alternative treatment option also increases. Radiation therapy constitutes an important component of standard cancer therapy, used either by itself or combined with surgery and chemotherapy. The increase in cancer diagnoses leads to a corresponding increase in the need for radiation therapy equipment and services. Also, heightened awareness and early screening initiatives result in a greater number of patients being diagnosed at treatable stages, further increasing radiation therapy usage. The steady increase in cancer cases guarantees long-term growth opportunities for radiation therapy technologies and service providers.

Growing Preference for Non-Invasive Treatments

Patients and healthcare providers prefer non-invasive cancer treatments, which has made radiation therapy a popular option. Surgery often carries substantial risks long recovery periods, and possible complications. In contrast, radiation therapy presents a less invasive choice with fewer immediate dangers. As the development in precision medicine increases the demand for radiation therapy also increases. In addition, precision medicine modalities such as image-guided radiation therapy (IGRT) and stereotactic body radiation therapy (SBRT), enables doctors to target tumors while protecting healthy tissue. This leads to improved patient results reduced side effects, and faster recovery. Many patients also favor radiation therapy because they can receive it as outpatients cutting down on hospital time. This shift toward non-invasive, patient-friendly treatments is boosting the use of radiation therapy across the globe.

Cancer Radiation Therapy Market Size and Share Analysis

By type, the cancer radiation therapy market is segmented into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment dominated the market in 2024. External Beam Radiation Therapy dominates due to its precision, non-invasive nature, ability to treat diverse cancers, widespread availability in hospitals, and continual technological advancements enhancing treatment outcomes.

By cancer type, the cancer radiation therapy market is segmented into breast cancer, lung cancer, prostate cancer, cervical cancer, head & neck cancer, colorectal cancer and others. The breast cancer segment dominated the market in 2024. Breast cancer leads this segment because of its global prevalence, standard radiation uses post-surgery, effective outcomes, and strong awareness campaigns driving early detection and consistent treatment protocols.

By end user, the market is segmented into hospitals, ambulatory & radiotherapy centers, specialty clinics, and academic & research institutes. The hospitals segment held the largest share of the market in 2024. Hospitals dominate as they offer full-spectrum oncology services, house advanced radiation equipment, have experienced oncology teams, and are typically the first point of diagnosis and referral for cancer patients.

Cancer Radiation Therapy Market Report Highlights

Cancer Radiation Therapy Market Report Coverage and Deliverables

The "Cancer Radiation Therapy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Medical cancer radiation therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Medical cancer radiation therapy market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed Porter's Five Forces and SWOT analysis
• Medical cancer radiation therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cancer radiation therapy market
• Detailed company profiles

Cancer Radiation Therapy Market Country and Regional Insights

The geographical scope of the cancer radiation therapy market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. The cancer radiation therapy market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia Pacific cancer radiation therapy market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh and Rest of Asia. The cancer radiation therapy market in Asia Pacific is the fastest growing market. Various factors are responsible for this growth such as rapid urbanization, rising cancer incidence, developing healthcare infrastructure, and others. China, India, Japan, and South Korea are experiencing rising cancer cases, which are driving demand for sophisticated radiation therapy products. Rising government initiative such as free cancer screening program, rising patient awareness is also responsible for further growth in this region. Additionally, investments in new radiotherapy equipment and oncology professional training enhance the level of treatment. Counter to difficulties like uneven rural healthcare access and expensive equipment, the market is aided by growing private sector involvement and public-private collaborations. Implementation of new technologies, such as proton therapy and Al-powered treatment planning, is picking up. The Asia Pacific market.

Cancer Radiation Therapy Market Research Report Guidance

• The report includes qualitative and quantitative data in the cancer radiation therapy market across type, cancer type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the cancer radiation therapy market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis along with Porter’s analysis.
• Chapter 5 highlights the major industry dynamics in the cancer radiation therapy market, including factors that are driving the market, prevailing deterrents, potential opportunities as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the cancer radiation therapy market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 9 cover cancer radiation therapy market segments by type, cancer type, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover market volume revenue forecast and factors driving the market.
• Chapter 10 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 11 describes the industry landscape analysis. It provides detailed description of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 12 provides detailed profiles of the major companies operating in the cancer radiation therapy market. The companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 13, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

Cancer Radiation Therapy Market News and Key Development:

The cancer radiation therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the cancer radiation therapy market are:

• In May 2024, Elekta announced the launch of its latest linear accelerator Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments. This highly versatile CT-Linac will enable clinicians to choose the most suitable radiation therapy technique for each individual patient.
• In August 2023, RefleXion Medical, a therapeutic oncology company, today announced that the first patient has completed treatment with SCINTIX biology-guided radiotherapy on the RefleXion X1 machine at the Stanford Medicine Cancer Center.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• World Endoscopy Organization
• Medicines and Healthcare Products Regulatory Agency (MHRA)
• Company website
• Company annual reports
• Company investor presentations

Cancer Radiation Therapy Market Strategic Insights

Cancer Radiation TherapyMarket Report Highlights

Cancer Radiation Therapy Market Country and Regional Insights